Journal of Clinical Endocrinology & Metabolism, Vol 44, 622-628, Copyright © 1977 by Endocrine Society

ARTICLES

Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease

A Tenore, WF Berman, JS Parks and AM Bongiovanni

Patients with inflammatory bowel disease (IBD) manifest growth failure which may antecede abdominal symptoms by some years. Eight of ten children with documented IBD had records of decreasing growth velocities. Investigation of growth hormone reserves showed excessive rather than impaired responses. Mean basal GH level was 6.2 +/- 0.75 (SEM) ng/ml. During sleep, the mean GH level rose to 26.0 +/- 4.7 ng/ml and following propranolol-glucagon stimulation, to 46.0 +/- 4.5 ng/ml. All values were significantly higher than levels obtained in a control population of 25 children investigated for short stature who were not GH deficient. The mean peak GH response following insulin in the IBD group (10.8 +/- 3.8 ng/ml), however, did not differ from the mean peak response in the control group (13.5 +/- 3.3 ng/ml). Growth failure in patients with IBD is not the result of GH deficiency and is not an irreversible phenomenon. On the contrary, judicious use of glucocorticoids aimed at the control of the disease usually produces compensatory growth acceleration ("catch-up growth").

This article has been cited by other articles:

				A. E. Wiskin, S. A. Wootton, and R. M. Beattie Nutrition Issues in Pediatric Crohn's Disease Nutr Clin Pract, April 1, 2007; 22(2): 214 - 222. [Abstract] [Full Text] [PDF]

				L. Katznelson, W. P. Fairfield, N. Zeizafoun, B. E. Sands, M. A. Peppercorn, D. I. Rosenthal, and A. Klibanski Effects of Growth Hormone Secretion on Body Composition in Patients with Crohn's Disease J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5468 - 5472. [Abstract] [Full Text] [PDF]

				F. De Benedetti, C. Meazza, M. Oliveri, P. Pignatti, M. Vivarelli, T. Alonzi, E. Fattori, S. Garrone, A. Barreca, and A. Martini Effect of IL-6 on IGF Binding Protein-3: A Study in IL-6 Transgenic Mice and in Patients with Systemic Juvenile Idiopathic Arthritis Endocrinology, November 1, 2001; 142(11): 4818 - 4826. [Abstract] [Full Text] [PDF]

				A.B. Ballinger, C. Camacho-Hubner, and N.M. Croft Growth failure and intestinal inflammation QJM, March 1, 2001; 94(3): 121 - 125. [Full Text] [PDF]

				G. Touati, A. M. Prieur, J. C. Ruiz, M. Noel, and P. Czernichow Beneficial Effects of One-Year Growth Hormone Administration to Children with Juvenile Chronic Arthritis on Chronic Steroid Therapy. I. Effects on Growth Velocity and Body Composition J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 403 - 409. [Abstract] [Full Text]